| 10/30 | SINOVAC BIOTECH : Brazil will buy China COVID-19 vaccine, VP Mourão says, contra.. | RE |
| 10/30 | NOVO NORDISK : Gets a Buy rating from Bernstein | MD |
| 10/30 | BAYER AG : Credit Suisse remains Neutral | MD |
| 10/30 | Pfizer, Mylan Agreement With FTC Over Upjohn Deal, Clearing Way for November .. | DJ |
| 10/30 | MERCK KGAA : Sell rating from Goldman Sachs | MD |
| 10/30 | NOVO NORDISK : Berenberg gives a Neutral rating | MD |
| 10/30 | Lonza to make COVID-19 antibody combination for AstraZeneca | RE |
| 10/30 | Wall St slumps as tech stocks slide, COVID cases jump | RE |
| 10/30 | ABBVIE : Correction to AbbVie Earnings Article | DJ |
| 10/30 | NOVO NORDISK A/S : 3Q Net Profit Rose as Pandemic Disruption EaseD -- Earnings R.. | DJ |
| 10/30 | NOVO NORDISK : Jefferies reaffirms its Sell rating | MD |
| 10/30 | NOVO NORDISK : Gets a Buy rating from JP Morgan | MD |
| 10/30 | NOVO NORDISK : UBS sticks Neutral | MD |
| 10/30 | ABBVIE : Logs 3Q Sales Growth on Higher Immunology, Oncology Results | DJ |
| 10/30 | NOVO NORDISK : Goldman Sachs keeps its Buy rating | MD |
| 10/30 | GLAXOSMITHKLINE : Sell rating from Barclays | MD |
| 10/30 | BIOGEN : EMA to review Biogen's aducanumab drug for Alzheimer's | RE |
| 10/30 | Pfizer, Astra Vaccine With Oxford Under Accelerated UK Reviews- Bloomberg Ne.. | RE |
| 10/30 | BIOGEN : EMA accepts Biogen's Alzheimer's treatment aducanumab for review | RE |
| 10/30 | ASTRAZENECA : sells commercial rights to two drugs in $400 million deal | RE |
| 10/30 | SANOFI : Receives a Buy rating from Credit Suisse | MD |
| 10/30 | GLAXOSMITHKLINE : Goldman Sachs reiterates its Buy rating | MD |
| 10/30 | SANOFI : JP Morgan remains its Buy rating | MD |
| 10/30 | ASTRAZENECA : to Sell Atacand Rights in Around 70 Countries for $400 Million | DJ |
| 10/30 | NOVO NORDISK A/S : 3Q Net Profit Rose Amid Destocking, New Patients | DJ |
| 10/30 | NOVO NORDISK A/S : sales rise as more diabetics seek treatment | RE |
| 10/30 | SANOFI : Goldman Sachs keeps its Buy rating | MD |
| 10/30 | BioNTech CEO expects data from late-stage study soon | RE |
| 10/30 | LONZA : to make COVID-19 antibody combination for AstraZeneca | RE |
| 10/29 | BIONTECH : Germany Aims to Start Coronavirus Vaccination This Year -- Update | DJ |
| 10/29 | EU to fund transfer of COVID-19 patients across borders to prevent hospitals .. | RE |
| 10/29 | EU Commission says talking to four companies on COVID vaccine | RE |
| 10/29 | Fauci says first U.S. COVID-19 vaccines could ship late December or early Jan.. | RE |
| 10/29 | GLAXOSMITHKLINE : Activists urge 'Big Pharma' to be transparent on COVID-19 vacc.. | RE |
| 10/29 | Arcus Biosciences Shares Rise 11% on AstraZeneca Partnership | DJ |
| 10/29 | BIONTECH : Germany Aims to Start Coronavirus Vaccination This Year | DJ |
| 10/29 | MERCK : Mammoth Biosciences Partner to Produce, Scale Up Covid-19 Test | DJ |
| 10/29 | Sanofi Says It Won EU Patent Ruling Against Amgen Over Cholesterol Drug -- Up.. | DJ |
| 10/29 | Moderna on track to report late-stage COVID-19 vaccine data next month | RE |
| 10/29 | Sanofi Says It Won EU Patent Ruling Against Amgen Over Cholesterol Drug | DJ |
| 10/29 | ACREAGE : Canada dry? Cannabis-infused drinks fizzle due to production, distribu.. | RE |
| 10/29 | GLAXOSMITHKLINE : Credit Suisse remains Neutral | MD |
| 10/29 | SANOFI : JP Morgan remains its Buy rating | MD |
| 10/29 | REGENERON PHARMACEUTICALS : Gets FDA Priority Review of Libtayo in Lung Cancer | DJ |
| 10/29 | ROCHE HOLDINGS AG : UBS keeps its Buy rating | MD |
| 10/29 | SANOFI : UBS maintains a Buy rating | MD |
| 10/29 | SANOFI : 3Q Profit Grew; Raises 2020 Business EPS Guidance -- Update | DJ |
| 10/29 | SHANGHAI FOSUN PHARMACEUTICAL : Nine-Month Net Profit Rose 20% | DJ |
| 10/29 | SANOFI : Receives a Buy rating from Goldman Sachs | MD |
| 10/29 | SHENZHEN KANGTAI BIOLOGICAL PRODUCTS : China's Kangtai starts mid-stage trial of.. | RE |
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
